Johns Hopkins University · FACULTY OF BIOLOGY

AS.410.604 Chap.5 TGF Beta and Pathway Shutdown

- one subject, every graph, every model, every mark
5 Chapters2-page Bible
Our own words - no uploaded lecturer files
Updated for this semester
Chapter 5 of 10 · AS.410.604

TGF Beta and Pathway Shutdown

Keep receptor and Smad roles ordered

Type II TGF-beta receptors recruit and activate type I receptors, which phosphorylate receptor-regulated Smads. R-Smads join co-Smad and move to the nucleus with transcriptional partners.

Inhibitory Smads, Smurf ubiquitin ligases and phosphatases restrain different steps, so competition, dephosphorylation and degradation should be diagnosed separately.

Build the receptor-to-nucleus sequence

Start with ligand-dependent receptor assembly. The type II receptor activates the type I receptor, and the type I kinase phosphorylates receptor-regulated Smads.

Activated R-Smads associate with a common-partner Smad and accumulate in the nucleus, where DNA-binding partners and co-regulators shape transcription. Each step provides a distinct readout: receptor-complex formation, receptor kinase state, R-Smad phosphorylation, complex formation, nuclear localisation and target-gene expression.

Normal nuclear entry with weak transcription moves analysis toward nuclear partners, chromatin context or inhibitory regulation rather than back to ligand binding.

Attach each brake to a molecular object

Inhibitory Smads can interfere with productive receptor or Smad signalling, Smurf-family ubiquitin ligases can promote degradation of selected components, and phosphatases reverse phosphorylation-dependent states.

These brakes are not interchangeable. Competition changes access without necessarily changing abundance, dephosphorylation changes activity state, and ubiquitin-linked turnover changes protein persistence. Measure total and phosphorylated protein together, use localisation information, and follow decay over time.

If a proteasome perturbation restores abundance but not transcription, the degraded protein may not have been the only limiting step.

Use time courses to distinguish activation from shutdown

An early normal phospho-Smad peak followed by unusually rapid loss suggests excessive termination, whereas no early peak points toward receptor activation or phosphorylation.

Persistent phosphorylation after ligand withdrawal suggests defective dephosphorylation or continued receptor input. Sample receptor, Smad and transcriptional states at matched times because their peaks need not coincide. Removal of ligand, selective receptor inhibition and phosphatase or degradation perturbations can test which process controls decline.

The experiment should include a target-engagement control and a downstream readout so that biochemical persistence is connected to function.

Interpret context-dependent transcription carefully

TGF-beta responses vary with cell state, available transcriptional partners and interaction with other pathways. Therefore, identical R-Smad nuclear localisation can accompany different gene programmes.

Compare a panel of direct targets, not one convenient marker, and test whether the proposed partner occupies or regulates the relevant locus. Rescue with a nuclear co-factor can place the defect below Smad entry, but overexpression may create non-physiological activity. A concise exam answer states the latest normal event, the first failed event and one discriminating assay.

It also separates pathway competence from the direction of a complex phenotype such as proliferation or differentiation.

In this chapter

What this chapter covers

  • 01

    Type II and type I receptors

  • 02

    R-Smad phosphorylation

  • 03

    Co-Smad complex

  • 04

    Inhibitory Smads

  • 05

    Smurf and phosphatases

Worked example · free

Localize low Smad reporter output

Q [6 marks]. R-Smad phosphorylation and nuclear entry are normal, but transcription remains low. Where should analysis move? The six-mark allocation is an AskSia revision aid, not an official Johns Hopkins marking scheme.
TGF-beta signaling couples a receptor complex to Smad transcriptional control.TGF-beta signaling couples a receptor complex to Smad transcriptional control. Inhibitory Smads, ubiquitin ligases and phosphatases restrain the same route at distinct points. TGFβ dimer RII activates RI R-Smad-P Smad gene control I-Smad / Smurf phosphatases reset Smads
TGF-beta signaling couples a receptor complex to Smad transcriptional control. Inhibitory Smads, ubiquitin ligases and phosphatases restrain the same route at distinct points.
  • 2Retain normal receptor events.
  • 2Retain nuclear import.
  • 2Test promoter cooperation.
The first supported problem lies at nuclear target selection, transcriptional partner availability or chromatin access, not at receptor assembly or Smad import.
Sia tip — Measure molecular state and compartment, not total abundance alone.
Glossary

Key terms

R Smad
An R Smad is phosphorylated by an active type I TGF-beta receptor.
Co Smad
A Co Smad joins activated R-Smads in a nuclear regulatory complex.
Inhibitory Smad
An Inhibitory Smad restrains receptor-to-Smad signaling through several mechanisms.
FAQ

TGF Beta and Pathway Shutdown FAQ

Which TGF-beta receptor acts first?

The type II receptor recruits and phosphorylates a type I receptor in the active complex. Type I then phosphorylates R-Smads. Reversing those roles breaks the source-supported sequence and obscures where receptor-state measurements localize a defect.

How do inhibitory Smads shut down signaling?

They can compete with R-Smads for receptor access, recruit Smurf ubiquitin ligases that promote receptor degradation, or recruit phosphatases. These actions differ in target, speed and persistence, so they require different measurements.

Why can one TGF-beta signal have different outcomes?

Nuclear Smad complexes cooperate with other transcription factors, and those partners plus chromatin access vary by cell type. Receptor activation can therefore be similar while target-gene selection and the resulting cell behavior differ.

Study strategy

Exam move

Trace type II receptor, type I receptor, R-Smad, co-Smad and nuclear partner. Attach each brake to its specific molecular target. Build a state table with total abundance, phosphorylation, complex formation, localisation and transcription in separate columns. Use it to distinguish receptor activation from Smad activation and nuclear entry from promoter function.

Next, place inhibitory Smad competition, phosphatase action and Smurf-mediated degradation on the exact molecules they change. Predict an early and late time point for each brake, because failed activation and accelerated shutdown can look similar at one endpoint.

For a normal nuclear Smad signal with low transcription, move to partner availability and chromatin access, then name an occupancy or reporter experiment that separates them. End by stating the latest normal event, the first failed event and the narrowest interval still supported, without assuming one cell type’s transcriptional output applies to every context.

Working through TGF Beta and Pathway Shutdown in AS.410.604? Sia is AskSia’s AI Biology tutor — ask any AS.410.604 TGF Beta and Pathway Shutdown question and get a clear, step-by-step explanation grounded in how AS.410.604 is taught and assessed. Read this chapter free, then take your hardest questions to Sia.

A+Everything unlocked
Unlocks this Bible + all 8 of your subjects at Johns Hopkins University, plus 1,000+ more Bibles across the AskSia library.
Sia - your AS410604 tutor, unlimited, worked the way the exam marks it
The full 2-page Bible + practice bank with worked solutions
Chrome extension - sync your LMS so Sia knows your deadlines
Bilingual EN / Chinese on every Bible and every Sia answer
$0.99 Trial
30-day money-back · cancel in one tap · how it works